Julie Earl
PhD, Hospital Universitario XBiografía y Trayectoria
Julie Earl, PhD in molecular biology from the University of Liverpool, UK (2003). Principal investigator in the Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS). Her main focus of research is the genetics of pancreatic cancer and the identification of germline variants that increase pancreatic cancer risk, as well as the identification and validation of biomarkers for early detection. Corresponding author on publications addressing pre-analytical standards in liquid biopsy, circulating biomarkers for the early detection of pancreatic cancer, and treatment-response monitoring. She has secured funding for ongoing industrial and international projects focused on biomarker research for the early detection of pancreatic cancer and is the PI and scientific lead on competitive private and intramural translational research grants, including funding to support a PhD student and a technician, and has supervised three PhD students who successfully defended their theses. She has published 66 articles (60 indexed in Web of Science), including 13 as corresponding author, with a cumulative impact factor of 644, over 2,061 citations, and an H-index of 23.
Líneas de Investigación Actuales
- Optimización de protocolos de aislamiento de ctDNA.
- Evaluación del valor pronóstico de las Células Tumorales Circulantes (CTCs).
- Desarrollo de paneles de secuenciación de nueva generación (NGS) adaptados a la biopsia líquida.
- Estudio de microvesículas y exosomas en la metástasis tumoral.
Publicaciones Destacadas
Puede consultar el listado completo en el perfil ORCID.
El Dr. Toledo ha publicado más de 50 artículos en revistas peer-reviewed, incluyendo *JAMA Oncology* y *Clinical Cancer Research*. Es revisor habitual de diversas revistas científicas internacionales y participa activamente en congresos internacionales.